New impact factor: The Lancet Journal

The Impact Factor has increased to 38.28, retaining our position as one of the leading general medicine journals in
the world (2011 Journal Citation Reports, Thomson Reuters, 2012). This result is evidence of the integrity researchers place on The Lancet's content.

Below is a list of the 10 most highly cited and ground-breaking articles which contributed to our new impact factor. To view the articles in full please click the button to the right of this message.
Click here to access them in full text: they are freely available in full.


Below is a list of the 10 most highly cited and ground-breaking articles which contributed to our new impact factor. To view the articles in full click here. They are freely available in full.

The top 10**

1. Global, regional, and national causes of child mortality in 2008: a
systematic analysis
(2010) The Lancet, 375 (9730), pp. 1969-1987.
Cited 324 times

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone
for treatment of HER2-positive advanced gastric or gastro-oesophageal
junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
(2010) The Lancet, 376 (9742), pp. 687- 97.
Cited 318 times

3. Incidence of 2009 pandemic influenza A H1N1 infection in England: a
cross-sectional serological study
(2010) The Lancet, 375 (9720), pp. 1100-1108.
Cited 290 times

4. Maternal mortality for 181 countries, 1980-2008: a systematic analysis
of progress towards Millennium Development Goal 5
(2010) The Lancet, 375 (9726), pp. 1609-1623.
Cited 281 times

5. Association of estimated glomerular filtration rate and albuminuria
with all-cause and cardiovascular mortality in general population cohorts:
a collaborative meta-analysis
(2010) The Lancet, 375 (9731), pp. 2073-2081.
Cited 263 times 6. Efficacy and safety of more intensive lowering of LDL
cholesterol: A meta-analysis of data from 170 000 participants in 26
randomised trials
(2010) The Lancet, 376 (9753), pp. 1670-1681.
Cited 262 times

7. Carotid artery stenting compared with endarterectomy in patients with
symptomatic carotid stenosis (International Carotid Stenting Study): an
interim analysis of a randomised controlled trial
(2010) The Lancet, 375 (9719), pp. 985-997.
Cited 255 times

8. C-reactive protein concentration and risk of coronary heart disease,
stroke, and mortality: an individual participant meta-analysis
(2010) The Lancet, 375 (9709), pp. 132-140.
Cited 233 times

9. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with
BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept
trial
(2010) The Lancet, 376 (9737), pp. 235-244.
Cited 225 times

10. Once-only flexible sigmoidoscopy screening in prevention of colorectal
cancer: a multicentre randomised controlled trial
(2010) The Lancet, 375 (9726), pp. 1624-1633.
Cited 211 times